Correlation Between SAB Biotherapeutics and Biomarin Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Biomarin Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Biomarin Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and Biomarin Pharmaceutical, you can compare the effects of market volatilities on SAB Biotherapeutics and Biomarin Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Biomarin Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Biomarin Pharmaceutical.
Diversification Opportunities for SAB Biotherapeutics and Biomarin Pharmaceutical
-0.5 | Correlation Coefficient |
Very good diversification
The 3 months correlation between SAB and Biomarin is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Biomarin Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomarin Pharmaceutical and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Biomarin Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomarin Pharmaceutical has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Biomarin Pharmaceutical go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and Biomarin Pharmaceutical
Assuming the 90 days horizon SAB Biotherapeutics is expected to generate 55.28 times more return on investment than Biomarin Pharmaceutical. However, SAB Biotherapeutics is 55.28 times more volatile than Biomarin Pharmaceutical. It trades about 0.11 of its potential returns per unit of risk. Biomarin Pharmaceutical is currently generating about -0.04 per unit of risk. If you would invest 5.00 in SAB Biotherapeutics on September 4, 2024 and sell it today you would earn a total of 0.17 from holding SAB Biotherapeutics or generate 3.4% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 75.15% |
| Values | Daily Returns |
SAB Biotherapeutics vs. Biomarin Pharmaceutical
Performance |
| Timeline |
| SAB Biotherapeutics |
| Biomarin Pharmaceutical |
SAB Biotherapeutics and Biomarin Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SAB Biotherapeutics and Biomarin Pharmaceutical
The main advantage of trading using opposite SAB Biotherapeutics and Biomarin Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Biomarin Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomarin Pharmaceutical will offset losses from the drop in Biomarin Pharmaceutical's long position.| SAB Biotherapeutics vs. SAB Biotherapeutics | SAB Biotherapeutics vs. Jasper Therapeutics | SAB Biotherapeutics vs. NRx Pharmaceuticals | SAB Biotherapeutics vs. Surrozen Warrant |
| Biomarin Pharmaceutical vs. Alnylam Pharmaceuticals | Biomarin Pharmaceutical vs. Exelixis | Biomarin Pharmaceutical vs. Halozyme Therapeutics | Biomarin Pharmaceutical vs. Arrowhead Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |